Continuous ST-segment monitoring: A non-invasive method of assessing myocardial perfusion in acute myocardial infarction

European Journal of Cardiovascular Nursing

Volumn 1, Issue 1, 2002, Pages 41-43

  Kucia, Angela M ^a,b   Stewart, Simon ^a,b   Zeitz, Christopher J ^a,c  

^a QUEEN ELIZABETH HOSPITAL   (Australia)

^b UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

^c UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

Acute myocardial infarction; ST segment monitoring

Indexed keywords

ACUTE HEART INFARCTION; ANGIOCARDIOGRAPHY; CONFERENCE PAPER; FIBRINOLYTIC THERAPY; HEART MUSCLE PERFUSION; HEART MUSCLE REPERFUSION; HUMAN; MEDICAL ASSESSMENT; PRIORITY JOURNAL; ST SEGMENT; SURVIVAL TIME; VASCULAR PATENCY;

ALGORITHMS; CORONARY ANGIOGRAPHY; CORONARY VESSELS; CRITICAL CARE; DECISION TREES; DRUG MONITORING; ELECTROCARDIOGRAPHY, AMBULATORY; HUMANS; MONITORING, PHYSIOLOGIC; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; NURSE'S ROLE; PREDICTIVE VALUE OF TESTS; THROMBOLYTIC THERAPY; TREATMENT OUTCOME; VASCULAR PATENCY;

EID: 0037491983     PISSN: 14745151     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1474-5151(01)00015-9     Document Type: Conference Paper

References (30)

1. Capewell S., MacIntyre K., Stewart S., et al. Age, sex and social trends in out-of-hospital cardiac deaths in Scotland 1986-1995: A retrospective cohort study. Lancet. 358:2001;1213-1217.
2. Veldkamp R.F., Green C.L., Wilkins M.L., et al. Comparison of continuous ST-segment recovery analysis with methods using static electrocardiograms for noninvasive patency assessment during acute myocardial infarction. Am J Cardiol. 73:1994;1069-1074.
3. Krucoff M.W., Cross M.A., Pope J.E., et al. Continuously updated 12-lead ST-segment recovery analysis for myocardial infarct artery patency assessment and its correlation with multiple simultaneous early angiographic observations. Am J Cardiol. 71:1993;145-151.
4. Clemmenson P., Ohman M., Sevilla D.C., et al. Changes in standard electrocardiographic ST-segment elevation predictive of successful reperfusion in acute myocardial infarction. Am J Cardiol. 66:1990;1407-1411.
5. Dellborg M., Topol E.J., Swedberg K. Dynamic QRS-complex and ST-segment vectorcardiographic monitoring can identify vessel patency in patients with acute myocardial infarction treated with reperfusion therapy. Am Heart J. 122:1991;943-948.
6. Kucia A.M., Stewart S. The role of ST-segment monitoring in assessment of acute myocardial infarction. Dim Crit Care Nurs. 18:1999;12-18.
7. Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet. 1:1986;397-402.
8. Randomized trial of intravenous streptokinase, oral aspirin, both or neither among 17187 cases of suspected acute myocardial infarction. Lancet. 2:1988;349.
9. Lincoff A.M., Topol E.J., Califf R.M., et al. Significance of a coronary artery with thrombolysis in myocardial infarction grade 2 flow 'patency' (outcome in the thrombolysis and angioplasty in myocardial infarction trials). Thrombolysis and Angioplasty in Myocardial Infarction Study Group. Am J Cardiol. 75:1995;871-876.
10. Shah A., Wagner G.S., Granger C.B., et al. Prognostic implications of TIMI flow grade in the infarct related artery compared with continuous 12-lead ST-segment resolution analysis. J Am Coll Cardiol. 35:2000;666-672.
11. Kircher B.J., Topol E.J., O'Neill W.W., Pitt B. Prediction of infarct coronary artery recanalization after intravenous thrombolytic therapy. Am J Cardiol. 59:1987;513-515.
12. Clemmenson P., Ohman E.M., Sevilla D.C., et al. Changes in standard electrocardiographic ST-segment elevation predictive of successful reperfusion in acute myocardial infarction. Am J Cardiol. 66:1990;1407-1411.
13. Habib G.B., Heibig J., Forman S.A., et al. Influence of coronary collateral vessels on myocardial infarct size in humans. Results of phase I thrombolysis in myocardial infarction (TIMI) trial. The TIMI Investigators. Circulation. 83:1991;739-746.
14. Perez-Castellano N., Garcia E.J., Abeytua M., et al. Influence of collateral circulation on in-hospital death from anterior acute myocardial infarction. J Am Coll Cardiol. 31:1998;512-518.
15. Veldkamp R.F., Pope J.E., Sawchak S.T., et al. ST-segment recovery as an endpoint in acute myocardial infarction trials: past, present and future. J Electrocardiol. 26:(Suppl):1993;256-261.
16. Hackett D., Davies G., Chiera S., Maseri A. Intermittent coronary occlusion in acute myocardial infarction. Value of combined thrombolytic and vasodilator therapy. N Engl J Med. 317:1987;1055-1059.
17. Krucoff M.W., Croll M.A., Pope J.E., et al. Continuously updated 12-lead ST-segment recovery analysis for myocardial infarct artery patency assessment and its correlation with multiple simultaneous early angiographic observations. Am J Cardiol. 71:1993;145-151.
18. Krucoff M.W., Croll M.A., Pope J.E., et al. Continuously updated 12-lead ST-segment recovery analysis for myocardial infarct artery patency assessment and its correlation with multiple simultaneous early angiographic observations. Am J Cardiol. 71:1993;145-151.
19. Langer A., Krucoff M.W., Klootwijk P., et al. for the GUSTO Investigators. Noninvasive assessment of speed and stability of infarct-related artery reperfusion: results of the GUSTO ST segment monitoring study. J Am Coll Cardiol. 25:1995;1552-1557.
20. Porter T.R., Li S., Oster R., et al. The clinical implications of no reflow demonstrated with intravenous perfluorocarbon containing microbubbles following restoration of thrombolysis in myocardial infarction (TIMI) 3 flow in patients with acute myocardial infarction. Am J Cardiol. 82:1998;1173-1177.
21. The thrombolysis in acute myocardial infarction (TIMI) trial: phase I findings. N Engl J Med. 312:1985;932.
22. The effects of tissue plasminogen activator, streptokinase, or both on coronary artery patency, ventricular function and survival after acute myocardial infarction. N Engl J Med. 329:1993;1615-1622.
23. Lincoff A.M., Topol E.J. Illusion of reperfusion. Does anyone achieve optimal reperfusion during acute myocardial infarction? Circulation. 88:1993;1361-1374.
24. Ohman E.M., Califf R.M., Topol E.J., et al. Consequences of reocclusion after successful reperfusion therapy in acute myocardial infarction. Circulation. 82:1990;781-791.
25. Sinkovic A. Prognostic role of plasminogen-activator-inhibitor-1 levels in treatment with streptokinase of patients with acute myocardial infarction. Clin Cardiol. 23:2000;486-489.
26. De Belder M. Acute myocardial infarction: failed thrombolysis. Heart. 85:2001;104-112.
27. Mattfeldt T., Schwarz F., Schuler G., et al. Necropsy evaluation in seven patients with evolving acute myocardial infarction treated with thrombolytic therapy. Am J Cardiol. 54:1984;530-534.
28. Richardson P.D., Davies M.J., Born G.V.R. Influence of plaque configuration and stress distribution on fissuring of atherosclerotic plaques. Lancet. 2:1989;941-944.
29. Ellis S.G., da Silva E.R., Hendrick G. Randomized comparison of rescue angioplasty with conservative management of patients with early failure of thrombolysis for acute myocardial infarction. Circulation. 90:1994;2280-2284.
30. Califf R.M., Topol E.J., Stock R.S., et al. Evaluation of thrombolytic therapy and timing of cardiac catheterization in acute myocardial infarction. Results of Thrombolysis and Angioplasty in Myocardial Infarction - Phase 5 randomized trial. Circulation. 83:1991;1543-1556.